• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型钙通道阻滞剂DMDP通过增加多柔比星在耐药P388细胞系中的滞留并抑制DNA修复来增强多柔比星诱导的细胞毒性。

Enhancement of adriamycin-induced cytotoxicity by increasing retention and inhibition of DNA repair in DOX-resistant P388 cell lines with new calcium channel blocker, DMDP.

作者信息

Bankusli I, Yin M B, Mazzoni A, Abdellah A J, Rustum Y M

机构信息

Grace Cancer Drug Center, Roswell Park Memorial Institute, Buffalo, NY 14263.

出版信息

Anticancer Res. 1989 May-Jun;9(3):567-74.

PMID:2764503
Abstract

The effect of DMDP, N-(3,4-dimethoxyphenethyl)-N-methyl-2-(2-naphthyl)-m-dithiane-2-propylam ine hydrochloride, on DOX-induced cytotoxicity, drug uptake, DNA damage and repair was investigated in adriamycin sensitive and resistant P388 cell lines. In vitro, the DOX-resistant P388 cells used are about 300-fold more resistant than the sensitive cells. Resistant cells were characterized by lower DOX accumulation, rapid drug efflux, significant decrease of DNA single and double strand breaks and rapid repair of the induced single strand breaks. DMDP, a calcium channel blocker, is an effective modulator of DOX resistance in P388 cells. This modulation was found to be highly dependent of the concentration of the modulators, optimal at the maximally moncytotoxic concentrations of 1-4 microM, and the duration of exposure to the modulator, optimal under conditions of continuous exposure to the modulator. Under the optimal conditions in the presence of the modulator, DMDP, both intracellular concentration and retention of DOX were restored in the resistant P388 cells to the value comparable to those found in DOX sensitive P388 cells. Even though DOX accumulation and retention were at a comparable level in both the sensitive and resistant cells in the presence of DMDP, the amount of DNA single strand breaks achieved in the resistant cells was only about 30% of the amount of damage observed in the sensitive cells. The data indicate that if P388/R cells were only exposed to DOX for about 2 h, the induced DNA single strand breaks were repaired rapidly within 8 h thereafter, while no significant repair was seen in the resistant cells exposed to DOX in combination with DMDP. In contrast, the repair of the extensive DNA single strand breaks induced by DOX in P388/S cells was not effected by DMDP. These data clearly demonstrated that resistance to DOX in P388 cells are multifactorial. Restoration of intracellular accumulation and retention of DOX by DMDP in the resistant cells are although necessary but not sufficient for complete restoration of the sensitivity of the highly resistant cells.

摘要

研究了盐酸N-(3,4-二甲氧基苯乙基)-N-甲基-2-(2-萘基)-间二硫杂环戊烷-2-丙胺(DMDP)对阿霉素敏感和耐药的P388细胞系中阿霉素诱导的细胞毒性、药物摄取、DNA损伤和修复的影响。在体外,所使用的阿霉素耐药P388细胞的耐药性比敏感细胞高约300倍。耐药细胞的特征是阿霉素积累较低、药物快速外排、DNA单链和双链断裂显著减少以及诱导的单链断裂快速修复。DMDP是一种钙通道阻滞剂,是P388细胞中阿霉素耐药性的有效调节剂。发现这种调节高度依赖于调节剂的浓度,在最大非细胞毒性浓度1-4 microM时最佳,还依赖于暴露于调节剂的持续时间,在持续暴露于调节剂的条件下最佳。在存在调节剂DMDP的最佳条件下,耐药P388细胞中阿霉素的细胞内浓度和滞留量恢复到与阿霉素敏感P388细胞中相当的值。尽管在存在DMDP的情况下,敏感细胞和耐药细胞中的阿霉素积累和滞留处于相当水平,但耐药细胞中产生的DNA单链断裂量仅为敏感细胞中观察到的损伤量的约30%。数据表明,如果P388/R细胞仅暴露于阿霉素约2小时,此后诱导的DNA单链断裂在8小时内迅速修复,而在与DMDP联合暴露于阿霉素的耐药细胞中未观察到显著修复。相反,DMDP对阿霉素在P388/S细胞中诱导的广泛DNA单链断裂的修复没有影响。这些数据清楚地表明,P388细胞对阿霉素的耐药性是多因素的。DMDP在耐药细胞中恢复阿霉素的细胞内积累和滞留虽然是必要的,但不足以完全恢复高耐药细胞的敏感性。

相似文献

1
Enhancement of adriamycin-induced cytotoxicity by increasing retention and inhibition of DNA repair in DOX-resistant P388 cell lines with new calcium channel blocker, DMDP.新型钙通道阻滞剂DMDP通过增加多柔比星在耐药P388细胞系中的滞留并抑制DNA修复来增强多柔比星诱导的细胞毒性。
Anticancer Res. 1989 May-Jun;9(3):567-74.
2
Mechanisms of the in vivo resistance to adriamycin and modulation by calcium channel blockers in mice.小鼠体内对阿霉素的耐药机制及钙通道阻滞剂的调节作用
Cancer Res. 1989 Sep 1;49(17):4729-33.
3
Modulation of doxorubicin-induced DNA lesions by verapamil, DMDP and dipyridamole in resistant P388 cell lines.维拉帕米、DMDP和双嘧达莫对耐药P388细胞系中阿霉素诱导的DNA损伤的调节作用
Anticancer Res. 1990 Mar-Apr;10(2A):327-32.
4
Effects of DMDP, a tiapamil analogue, on adriamycin efflux in adriamycin-resistant and -sensitive P388 cells.替阿帕米类似物DMDP对阿霉素耐药及敏感P388细胞中阿霉素外排的影响。
Anticancer Res. 1987 Nov-Dec;7(6):1105-8.
5
Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.对阿霉素的耐药性:阿霉素敏感和耐药的P388白血病克隆细胞系中细胞毒性与药物摄取及DNA单链和双链断裂的关系。
Cancer Res. 1986 Jun;46(6):2978-83.
6
Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.对阿霉素的多因素抗性:阿霉素敏感和抗性P388白血病克隆细胞系中DNA修复、谷胱甘肽转移酶活性、药物外排和P-糖蛋白的关系。
Cancer Res. 1988 Jul 1;48(13):3595-602.
7
Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells.钙调蛋白抑制剂三氟拉嗪对阿霉素(多柔比星)耐药的P388小鼠白血病细胞中蒽环类药物的细胞内蓄积、滞留及细胞毒性的差异作用
Cancer Res. 1984 Nov;44(11):5056-61.
8
Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.不同蒽环类抗生素化学结构在多药耐药细胞中的交叉耐药相关性
Pathol Biol (Paris). 1994 Apr;42(4):328-37.
9
In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranes.阿霉素(一种对脂质膜具有高亲和力的蒽环类衍生物)诱导的体外细胞毒性、细胞药理学及DNA损伤
Cancer Res. 1993 Apr 1;53(7):1583-9.
10
Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentration.多药耐药人骨髓瘤细胞中DNA损伤与细胞内阿霉素浓度的直接关系。
Cancer Res. 1988 Nov 15;48(22):6360-4.

引用本文的文献

1
A proteomic analysis of chemoresistance development via sequential treatment with doxorubicin reveals novel players in MCF‑7 breast cancer cells.通过阿霉素序贯处理揭示 MCF-7 乳腺癌细胞中化疗耐药发展的蛋白质组分析揭示新的参与者。
Int J Mol Med. 2018 Oct;42(4):1987-1997. doi: 10.3892/ijmm.2018.3781. Epub 2018 Jul 18.